Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Dex Liquidating Co. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 24, 2012
Cardica, Inc.
(Exact Name of Registrant as Specified in Charter)
|
Delaware
(State or Other Jurisdiction
of Incorporation)
|
000-51772
(Commission
File Number)
|
94-3287832
(IRS Employer
Identification No.)
|
|
900 Saginaw Drive, Redwood City, CA
(Address of Principal Executive Offices)
|
94063
(Zip Code)
|
Registrant’s telephone number, including area code: (650) 364-9975
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events
On July 24, 2012, Cardica, Inc. (the “Company”) resumed its European clinical trial for its MicroCutter cutting/stapling device. The press release dated July 24, 2012, titled “Cardica Resumes MicroCutter™ Clinical Study in Europe” is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
(d) Exhibits
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press release titled “Cardica Resumes MicroCutter™ Clinical Study in Europe” dated July 24, 2012.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Cardica, Inc.
(Registrant)
|
||||
|
Date: July 24, 2012
|
/s/ Robert Y. Newell, IV
|
|||
|
Robert Y. Newell, IV
|
||||
|
Chief Financial Officer
|
||||
Exhibit Index
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press release titled “Cardica Resumes MicroCutter™ Clinical Study in Europe” dated July 24, 2012.
|